Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
BioSpace
Fri, 04/26/24 - 11:17 am
Tags:
Gilead Sciences
,
earnings
FDA mandates label updates on CAR-T cancer therapies
Reuters
Thu, 04/18/24 - 10:34 pm
Tags:
CAR-T
,
FDA
,
warning
,
cancer
,
Gilead Sciences
,
Bristol Myers Squibb
,
2seventybio
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
Tags:
biotech
,
M&A
,
IPOs
,
CG Oncology
,
Kyverna Therapeutics
,
Contineum Therapeutics
,
Boundless Bio
,
CymaBay Therapeutics
,
Gilead Sciences
,
MorphoSys
,
Novartis
,
Fusion Pharmaceuticals
,
AstraZeneca
,
Ambryx
,
JNJ
,
Inhibrix
,
Aventis
Gilead dives deeper into Nurix protein degrader collab, paying $15M for 2-year extension
Fierce Biotech
Tue, 04/2/24 - 11:38 am
Tags:
Gilead Sciences
,
Nurix Therapeutics
,
protein degradation
FDA approves Gilead's Vemlidy drug for children with hepatitis B
Investing.com
Thu, 03/28/24 - 05:08 pm
Tags:
Gilead Sciences
,
FDA
,
Vemlidy
,
hepatitis B
,
pediatric
Gilead bets on Xilio cancer drug as biotech restructures
BioPharma Dive
Thu, 03/28/24 - 11:54 am
Tags:
Gilead Sciences
,
Xilio Therapeutics
,
cancer
,
immunotherapy
,
restructuring
,
XTX301
,
solid tumors
Gilead CAR-T cancer therapy capacity to quadruple by 2026
Reuters
Fri, 03/15/24 - 10:57 am
Tags:
Gilead Sciences
,
cell therapy
,
cancer
,
drug manufacturing
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan
Stat
Thu, 03/14/24 - 06:25 pm
Tags:
Gilead Sciences
,
obeldesivir
,
Ebola Sudan
,
antivirals
Gilead tries new triple-target T-cell engagers in $1.5B-plus Merus collab
Fierce Biotech
Wed, 03/6/24 - 11:30 am
Tags:
Gilead Sciences
,
Merus
,
T-cell engager
Gilead Secures $210M from VC to Build Trodelvy’s Clinical Case in NSCLC
BioSpace
Fri, 03/1/24 - 11:48 am
Tags:
Gilead Sciences
,
funding
,
Trodelvy
,
non-small cell lung cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
Tags:
oncology
,
clinical trials
,
Daiichi Sankyo
,
AstraZeneca
,
Enhertu
,
metastatic breast cancer
,
Gilead Sciences
,
Trodelvy
,
bladder cancer
,
GSK
,
Zejula
,
Jemperli
,
ovarian cancer
,
Roche
,
tiragolumab
,
Tecentriq
,
non-small cell lung cancer
,
Cue Biopharma
,
CUE-101
,
head and neck cancer
,
Elicio Therapeutics
,
ELI-002
,
solid tumors
PhRMA, navigating turbulence, taps Gilead CEO to helm board of directors
Fierce Pharma
Wed, 02/21/24 - 10:43 pm
Tags:
PhRMA
,
lobbying
,
Daniel O'Day
,
Gilead Sciences
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials
Reuters
Thu, 02/15/24 - 07:14 pm
Tags:
Gilead Sciences
,
magrolimab
,
solid tumors
Gilead pays $4.3B for CymaBay, the biotech that never gave up on liver disease med
Fierce Biotech
Mon, 02/12/24 - 11:53 am
Tags:
Gilead Sciences
,
CymaBay Therapeutics
,
M&A
,
liver disease
,
seladelpar
,
primary biliary cholangitis
FDA puts hold on Gilead's blood cancer therapy trials
Reuters
Wed, 02/7/24 - 09:20 pm
Tags:
Gilead Sciences
,
FDA
,
clinical trials
,
magrolimab
,
blood cancer
Gilead will not buy Tizona after paying $300M for the right to do so
Fierce Biotech
Wed, 02/7/24 - 11:17 am
Tags:
Gilead Sciences
,
Tizona Therapeutics
,
M&A
,
oncology
Amgen earnings boosted by Horizon deal, Gilead quarterly revenue drops
Medical Marketing and Media
Tue, 02/6/24 - 11:41 pm
Tags:
Amgen
,
Gilead Sciences
,
earnings
,
Horizon Therapeutics
,
M&A
Gilead-backed Kyverna Therapeutics aims for $857.3 mln valuation in upsized IPO
Reuters
Tue, 02/6/24 - 09:17 am
Tags:
Kyvera Therapeutics
,
IPOs
,
Gilead Sciences
,
autoimmune diseases
Gilead invests $320M in Arcus to increase stake to 33%
Medical Marketing and Media
Wed, 01/31/24 - 10:32 pm
Tags:
Gilead Sciences
,
Arcus Biosciences
,
immuno-oncology
Gilead’s Kite Gets FDA Approval for Faster CAR T Therapy Manufacturing
BioSpace
Wed, 01/31/24 - 11:58 am
Tags:
Gilead Sciences
,
Kite Pharma
,
FDA
,
drug manufacturing
,
Yescarta
,
CAR-T
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.